One and two year outcomes of filgotinib in ulcerative colitis in a large real-world cohort

Jyseleca (filgotinib) - Gilead

https://gut.bmj.com/content/75/Suppl_1/A194

Clara Ramos-Belinchon1; Magdalena Staworko2; Beatriz Gros3; Jack Nicholls1; Marina Orti Cuerva3; Eksha Gupta1; Nathan Constantine-Cooke4; Elliot Gemmell5; Ian Arnott1; Charlie Lees5; Nikolas Plevris1

Jul 7, 2026